tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ANIP Stock Latest News

ANI Pharmaceuticals Projects Strong Growth for 2025
Company AnnouncementsANI Pharmaceuticals Projects Strong Growth for 2025
5d ago
8K
ANIP
ANI Pharmaceuticals sees FY24 adjusted EPS, revenue ‘at or above’ guidance
PremiumThe Fly
ANI Pharmaceuticals sees FY24 adjusted EPS, revenue ‘at or above’ guidance
5d ago
ANIP
ANI Pharmaceuticals sees Q4 Purified Cortrophin Gel revenue $59.2M-$59.8M
PremiumThe Fly
ANI Pharmaceuticals sees Q4 Purified Cortrophin Gel revenue $59.2M-$59.8M
5d ago
ANIP
ANI Pharmaceuticals sees FY25 revenue $739M-$759M, consensus $720.3M
PremiumThe Fly
ANI Pharmaceuticals sees FY25 revenue $739M-$759M, consensus $720.3M
5d ago
ANIP
ANI Pharmaceuticals launches Prucalopride Tablets after FDA approval
PremiumThe Fly
ANI Pharmaceuticals launches Prucalopride Tablets after FDA approval
16d ago
ANIP
ANI Pharmaceuticals initiated with an Outperform at Leerink
PremiumThe FlyANI Pharmaceuticals initiated with an Outperform at Leerink
1M ago
ANIP
ANI Pharmaceuticals Advances Amidst Regulatory and Market Challenges
Premium
Company Announcements
ANI Pharmaceuticals Advances Amidst Regulatory and Market Challenges
2M ago
8K
ANIP
ANI Pharmaceuticals’ Record Growth and Strategic Acquisition
Premium
Company Announcements
ANI Pharmaceuticals’ Record Growth and Strategic Acquisition
2M ago
ANIP
ANI Pharmaceuticals reports Q3 adjusted EPS $1.34, consensus $1.09
PremiumThe Fly
ANI Pharmaceuticals reports Q3 adjusted EPS $1.34, consensus $1.09
2M ago
ANIP
ANI Pharmaceuticals raises FY24 adj. EPS view to $4.90-$5.05 from $4.38-$4.82
PremiumThe Fly
ANI Pharmaceuticals raises FY24 adj. EPS view to $4.90-$5.05 from $4.38-$4.82
2M ago
ANIP
Ani Pharmaceuticals (ANIP) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Ani Pharmaceuticals (ANIP) Q3 Earnings Cheat Sheet
2M ago
ANIP
ANI Pharmaceuticals announces FDA approval of Estradiol Gel, 0.06%
PremiumThe Fly
ANI Pharmaceuticals announces FDA approval of Estradiol Gel, 0.06%
3M ago
ANIP
ANI Pharmaceuticals price target raised to $62 from $60 at Truist
PremiumThe FlyANI Pharmaceuticals price target raised to $62 from $60 at Truist
3M ago
ANIP
EYPT
ANI Pharmaceuticals initiated with an Overweight at Piper Sandler
Premium
The Fly
ANI Pharmaceuticals initiated with an Overweight at Piper Sandler
3M ago
ANIP
ANI Pharmaceuticals announces FDA approval, launch of Ketoconazole Shampoo, 2%
Premium
The Fly
ANI Pharmaceuticals announces FDA approval, launch of Ketoconazole Shampoo, 2%
4M ago
ANIP
ANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
PremiumThe Fly
ANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
4M ago
ANIP
ANI Pharmaceuticals completes acquisition of Alimera Sciences
PremiumThe Fly
ANI Pharmaceuticals completes acquisition of Alimera Sciences
4M ago
ALIM
ANIP
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
PremiumThe Fly
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
4M ago
ALIM
ANIP
ANI Pharmaceuticals launches Promethazine Hydrochloride
PremiumThe Fly
ANI Pharmaceuticals launches Promethazine Hydrochloride
4M ago
ANIP
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
PremiumThe FlySalesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
4M ago
AR
MS
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
Premium
The Fly
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
4M ago
ALIM
ANIP
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
Premium
The Fly
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
4M ago
ALIM
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >